CA-170
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Tumors or Lymphomas
Conditions
Advanced Solid Tumors or Lymphomas
Trial Timeline
May 1, 2016 → May 7, 2020
NCT ID
NCT02812875About CA-170
CA-170 is a phase 1 stage product being developed by Curis for Advanced Solid Tumors or Lymphomas. The current trial status is completed. This product is registered under clinical trial identifier NCT02812875. Target conditions include Advanced Solid Tumors or Lymphomas.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02812875 | Phase 1 | Completed |
Competing Products
20 competing products in Advanced Solid Tumors or Lymphomas